| 1 |
Skrobot OA, Black SE, Chen C, et al. Progress toward standardized diagnosis of vascular cognitive impairment: Guidelines from the Vascular Impairment of Cognition Classification Consensus Study [J]. Alzheimers Dement, 2018, 14(3): 280-292.
|
| 2 |
Satizabal CL, Beiser AS, Chouraki V, et al. Incidence of dementia over three decades in the Framingham Heart Study [J]. N Engl J Med, 2016, 374(6): 523-532.
|
| 3 |
Norton S, Matthews FE, Barnes DE, et al. Potential for primary prevention of Alzheimer's disease: an analysis of population-based data [J]. Lancet Neurol, 2014, 13(8): 788-794.
|
| 4 |
Skrobot OA, O'Brien J, Black S, et al. The vascular impairment of cognition classification consensus study [J]. Alzheimers Dement, 2017, 13(6): 624-633.
|
| 5 |
中国医师协会神经内科分会认知障碍专业委员会编写组. 2019年中国血管性认知障碍诊治指南 [J]. 中华医学杂志, 2019, 99(35): 2737-2744.
|
| 6 |
Jia J, Wang F, Wei C, et al. The prevalence of dementia in urban and rural areas of China [J]. Alzheimers Dement, 2014, 10(1): 1-9.
|
| 7 |
Jia J, Zhou A, Wei C, et al. The prevalence of mild cognitive impairment and its etiological subtypes in elderly Chinese [J]. Alzheimers Dement, 2014, 10(4): 439-447.
|
| 8 |
Sharp SI, Aarsland D, Day S, et al. Hypertension is a potential risk factor for vascular dementia: systematic review [J]. Int J Geriatr Psychiatry, 2011, 26(7): 661-669.
|
| 9 |
Moll VCE, Richard E, Eurelings LS, et al. Effectiveness of a 6-year multidomain vascular care intervention to prevent dementia (preDIVA): a cluster-randomised controlled trial [J]. Lancet, 2016, 388(10046): 797-805.
|
| 10 |
Kavirajan H, Schneider LS. Efficacy and adverse effects of cholinesterase inhibitors and memantine in vascular dementia: a meta-analysis of randomised controlled trials [J]. Lancet Neurol, 2007, 6(9): 782-792.
|
| 11 |
Qizilbash N, Gregson J, Johnson ME, et al. BMI and risk of dementia in two million people over two decades: a retrospective cohort study [J]. Lancet Diabetes Endocrinol, 2015, 3(6): 431-436.
|
| 12 |
Noh HM, Han J, Kim YJ, et al. Sex differences in the relationship between cognitive impairment and overweight or obesity in late life: A 3-year prospective study [J]. Medicine (Baltimore), 2019, 98(9): e14736.
|
| 13 |
Hou Q, Guan Y, Yu W, et al. Associations between obesity and cognitive impairment in the Chinese elderly: an observational study [J]. Clin Interv Aging, 2019, 14: 367-373.
|
| 14 |
Wang F, Zhao M, Han Z, et al. Association of body mass index with amnestic and non-amnestic mild cognitive impairment risk in elderly [J]. BMC Psychiatry, 2017, 17(1): 334.
|
| 15 |
Arnoldussen I, Gustafson DR, Leijsen E, et al. Adiposity is related to cerebrovascular and brain volumetry outcomes in the RUN DMC study [J]. Neurology, 2019, 93(9): e864-e878.
|
| 16 |
West NA, Lirette ST, Cannon VA, et al. Adiposity, change in adiposity, and cognitive decline in mid- and late Life [J]. J Am Geriatr Soc, 2017, 65(6): 1282-1288.
|
| 17 |
Zhang T, Yan R, Chen Q, et al. Body mass index, waist-to-hip ratio and cognitive function among Chinese elderly: a cross-sectional study [J]. BMJ Open, 2018, 8(10): e22055.
|
| 18 |
Albanese E, Launer LJ, Egger M, et al. Body mass index in midlife and dementia: Systematic review and meta-regression analysis of 589,649 men and women followed in longitudinal studies [J]. Alzheimers Dement (Amst), 2017, 8: 165-178.
|
| 19 |
Jung UJ, Choi MS. Obesity and its metabolic complications: the role of adipokines and the relationship between obesity, inflammation, insulin resistance, dyslipidemia and nonalcoholic fatty liver disease [J]. Int J Mol Sci, 2014, 15(4): 6184-6223.
|
| 20 |
Miller AA, Spencer SJ. Obesity and neuroinflammation: a pathway to cognitive impairment [J]. Brain Behav Immun, 2014, 42: 10-21.
|
| 21 |
Hsieh CC, Chou MJ, Wang CH. Lunasin attenuates obesity-related inflammation in RAW264.7 cells and 3T3-L1 adipocytes by inhibiting inflammatory cytokine production [J]. PLoS One, 2017, 12(2): e171969.
|
| 22 |
Elias MF, Goodell AL, Dore GA. Hypertension and cognitive functioning: a perspective in historical context [J]. Hypertension, 2012, 60(2): 260-268.
|
| 23 |
Santisteban MM, Iadecola C. Hypertension, dietary salt and cognitive impairment [J]. J Cereb Blood Flow Metab, 2018, 38(12): 2112-2128.
|
| 24 |
Gottesman RF, Schneider AL, Albert M, et al. Midlife hypertension and 20-year cognitive change: the atherosclerosis risk in communities neurocognitive study [J]. JAMA Neurol, 2014, 71(10): 1218-1227.
|
| 25 |
Wardlaw JM, Smith EE, Biessels GJ, et al. Neuroimaging standards for research into small vessel disease and its contribution to ageing and neurodegeneration [J]. Lancet Neurol, 2013, 12(8): 822-838.
|
| 26 |
Huijts M, Duits A, Staals J, et al. Basal ganglia enlarged perivascular spaces are linked to cognitive function in patients with cerebral small vessel disease [J]. Curr Neurovasc Res, 2014, 11(2): 136-141.
|
| 27 |
Benjamin P, Lawrence AJ, Lambert C, et al. Strategic lacunes and their relationship to cognitive impairment in cerebral small vessel disease [J]. Neuroimage Clin, 2014, 4: 828-837.
|
| 28 |
Zeestraten EA, Lawrence AJ, Lambert C, et al. Change in multimodal MRI markers predicts dementia risk in cerebral small vessel disease [J]. Neurology, 2017, 89(18): 1869-1876.
|
| 29 |
Gao Z, Wang W, Wang Z, et al. Cerebral microbleeds are associated with deep white matter hyperintensities, but only in hypertensive patients [J]. PLoS One, 2014, 9(3): e91637.
|
| 30 |
Moroney JT, Tang MX, Berglund L, et al. Low-density lipoprotein cholesterol and the risk of dementia with stroke [J]. JAMA, 1999, 282(3): 254-260.
|
| 31 |
de Oliveira J, Engel DF, de Paula GC, et al. LDL receptor deficiency does not alter brain amyloid-beta levels but causes an exacerbation of apoptosis [J]. J Alzheimers Dis, 2020, 73(2): 585-596.
|
| 32 |
Alzoubi KH, Khabour OF, Salah HA, et al. Vitamin E prevents high-fat high-carbohydrates diet-induced memory impairment: the role of oxidative stress [J]. Physiol Behav, 2013, 119: 72-78.
|
| 33 |
Sawmiller D, Habib A, Hou H, et al. A novel apolipoprotein E antagonist functionally blocks apolipoprotein E interaction with N-terminal amyloid precursor protein, reduces beta-amyloid-associated pathology, and improves cognition [J]. Biol Psychiatry, 2019, 86(3): 208-220.
|
| 34 |
Chuang YF, Hayden KM, Norton MC, et al. Association between APOE epsilon4 allele and vascular dementia: The Cache County study [J]. Dement Geriatr Cogn Disord, 2010, 29(3): 248-253.
|
| 35 |
Han Y, Zhou A, Li F, et al. Apolipoprotein E epsilon4 allele is associated with vascular cognitive impairment no dementia in Chinese population [J]. J Neurol Sci, 2019, 409: 116606.
|
| 36 |
Menezes AR, Lavie CJ, Milani RV, et al. The effects of statins on prevention of stroke and dementia: a review [J]. J Cardiopulm Rehabil Prev, 2012, 32(5): 240-249.
|
| 37 |
Ebady SA, Arami MA, Shafigh MH. Investigation on the relationship between diabetes mellitus type 2 and cognitive impairment [J]. Diabetes Res Clin Pract, 2008, 82(3): 305-309.
|
| 38 |
Neth BJ, Craft S. Insulin resistance and alzheimer's disease: Bioenergetic Linkages [J]. Front Aging Neurosci, 2017, 9: 345.
|
| 39 |
de la Monte SM. Insulin resistance and Alzheimer's disease [J]. BMB Rep, 2009, 42(8): 475-481.
|
| 40 |
Reese LC, Laezza F, Woltjer R, et al. Dysregulated phosphorylation of Ca(2+) /calmodulin-dependent protein kinase II-alpha in the hippocampus of subjects with mild cognitive impairment and Alzheimer's disease [J]. J Neurochem, 2011, 119(4): 791-804.
|
| 41 |
Li X, Gao Y, Meng Z, et al. Regulatory role of microRNA-30b and plasminogen activator inhibitor-1 in the pathogenesis of cognitive impairment [J]. Exp Ther Med, 2016, 11(5): 1993-1998.
|
| 42 |
Jin L, Li YP, Feng Q, et al. Cognitive deficits and Alzheimer-like neuropathological impairments during adolescence in a rat model of type 2 diabetes mellitus [J]. Neural Regen Res, 2018, 13(11): 1995-2004.
|
| 43 |
Murillo OB, Ramirez EJ, Ramos-Rodriguez E, et al. Brain-derived neurotrophic factor plasma levels and premature cognitive impairment/dementia in type 2 diabetes [J]. World J Diabetes, 2016, 7(20): 615-620.
|